Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Active Not Recruiting Phase 2 Trials for Decitabine (DB01262)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0115568 (Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03404193 | Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome | Treatment |